Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$158M |
| 2 |
Match Group
MTCH
|
+$112M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$62M |
| 4 |
Adobe
ADBE
|
+$51M |
| 5 |
KKR & Co
KKR
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$486M |
| 2 |
PPLI
People Inc
PPLI
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
Alibaba
BABA
|
+$109M |
| 5 |
Fastly Inc
FSLY
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Phathom Pharmaceuticals
PHAT
$692M
| $49K | ﹤0.01% |
1,323
-489
| -27% | -$16.9K |
|
2702
Syndax Pharmaceuticals
SNDX
$1.82B
| $49K | ﹤0.01% |
3,322
-1,124
| -25% | -$17.1K |
|
2703
The Bancorp
TBBK
$2.84B
| $49K | ﹤0.01% |
5,686
-2,067
| -27% | -$19K |
|
2704
Turkcell
TKC
$4.79B
| $49K | ﹤0.01% |
10,317
| – | – |
|
|
FRG
2705
DELISTED
Franchise Group, Inc.
FRG
| $49K | ﹤0.01% |
1,951
-565
| -22% | -$13.5K |
|
|
CPLG
2706
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $49K | ﹤0.01% |
9,009
-8,884
| -50% | -$47K |
|
|
ALTA
2707
DELISTED
Altabancorp
ALTA
| $49K | ﹤0.01% |
2,441
-666
| -21% | -$13.6K |
|
|
TAST
2708
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $48K | ﹤0.01% |
7,455
-1,347
| -15% | -$8.35K |
|
|
VRAY
2709
DELISTED
ViewRay, Inc.
VRAY
| $48K | ﹤0.01% |
13,778
-4,875
| -26% | -$13.6K |
|
|
JCAP
2710
DELISTED
Jernigan Capital, Inc.
JCAP
| $48K | ﹤0.01% |
2,790
-841
| -23% | -$13.5K |
|
2711
BioLife Solutions
BLFS
$1.7B
| $47K | ﹤0.01% |
1,634
+524
| +47% | +$11.3K |
|
|
KC
2712
Kingsoft Cloud Holdings
KC
$3.69B
| $47K | ﹤0.01% |
+1,598
| New | +$54.6K |
|
|
SILV
2713
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $47K | ﹤0.01% |
5,582
+2,688
| +93% | +$25.4K |
|
|
EVFM
2714
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $47K | ﹤0.01% |
1,323
+41
| +3% | +$1.78K |
|
|
APLT
2715
DELISTED
Applied Therapeutics
APLT
| $46K | ﹤0.01% |
2,196
-570
| -21% | -$14.8K |
|
2716
Ecovyst
ECVT
$1.14B
| $46K | ﹤0.01% |
4,464
-1,571
| -26% | -$19.2K |
|
2717
Franklin Covey
FC
$246M
| $46K | ﹤0.01% |
2,570
-469
| -15% | -$9K |
|
2718
Global Industrial
GIC
$1.49B
| $46K | ﹤0.01% |
1,899
-537
| -22% | -$11.6K |
|
2719
Hyster-Yale Materials Handling
HY
$665M
| $46K | ﹤0.01% |
1,248
-2,367
| -65% | -$93.2K |
|
2720
i3 Verticals
IIIV
$342M
| $46K | ﹤0.01% |
1,819
-637
| -26% | -$17.1K |
|
2721
Turning Point Brands
TPB
$1.74B
| $46K | ﹤0.01% |
1,660
+6
| +0.4% | +$176 |
|
2722
Vertex
VERX
$1.94B
| $46K | ﹤0.01% |
+2,000
| New | +$48.7K |
|
2723
Wave Life Sciences
WVE
$1.2B
| $46K | ﹤0.01% |
5,392
-615
| -10% | -$6.74K |
|
|
MORF
2724
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $46K | ﹤0.01% |
1,680
-579
| -26% | -$15.2K |
|
|
NPTN
2725
DELISTED
NEOPHOTONICS CORP
NPTN
| $46K | ﹤0.01% |
7,480
-1,899
| -20% | -$14.5K |
|
Similar funds
Legal & General Group's Q3 2020 Portfolio in Review
As of Q3 2020, Legal & General Group held 3,476 positions worth $224B, up 8.1% from $207B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 3.2%. Legal & General Group opened 73 new positions and exited 39, leaving the 3,476-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Legal & General Group's largest Q3 2020 buy was AstraZeneca: 305,330 shares worth $33.5M.
- Legal & General Group added most to Zoom in Q3 2020, an estimated $158M increase.
- Legal & General Group's biggest Q3 2020 reduction was Apple, cutting an estimated $486M.
- Legal & General Group fully exited 58.com Inc in Q3 2020, selling an estimated $44.9M.
- Legal & General Group's ten largest holdings make up 22% of its $224B portfolio in Q3 2020.
- Legal & General Group opened 73 new positions and closed 39 in Q3 2020.
- Legal & General Group's portfolio value rose 8.1% quarter-over-quarter to $224B.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.